{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:46:51Z","timestamp":1778924811307,"version":"3.51.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"DOI":"10.1093\/toxsci\/kfu160","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T06:20:20Z","timestamp":1408688420000},"page":"105-116","source":"Crossref","is-referenced-by-count":16,"title":["Systems Level Metabolic Phenotype of Methotrexate Administration in the Context of Non-alcoholic Steatohepatitis in the Rat"],"prefix":"10.1093","volume":"142","author":[{"given":"Michael","family":"Kyriakides","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhiannon N.","family":"Hardwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaosheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Goedken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J.","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muireann","family":"Coen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,8,21]]},"reference":[{"key":"key\n\t\t\t\t20171012072819_B1","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert","year":"2007","journal-title":"Nat. Protoc."},{"key":"key\n\t\t\t\t20171012072819_B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2004-823098","article-title":"Nonalcoholic steatohepatitis","volume":"24","author":"Brunt","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"key\n\t\t\t\t20171012072819_B3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0002-9610(96)00392-3","article-title":"L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease","volume":"173","author":"Burke","year":"1997","journal-title":"Am. J. Surg."},{"key":"key\n\t\t\t\t20171012072819_B4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1177\/0192623311422082","article-title":"Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies","volume":"39","author":"Burkhardt","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"key\n\t\t\t\t20171012072819_B5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/ac048630x","article-title":"Statistical total correlation spectroscopy: An exploratory approach for latent biomarker identification from metabolic 1H NMR data sets","volume":"77","author":"Cloarec","year":"2005","journal-title":"Anal. Chem."},{"key":"key\n\t\t\t\t20171012072819_B6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13547500410001720767","article-title":"Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats: Implications for biomarker discovery","volume":"9","author":"Connor","year":"2004","journal-title":"Biomarkers"},{"key":"key\n\t\t\t\t20171012072819_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/503028","article-title":"Methotrexate in atherogenesis and cholesterol metabolism","volume":"2011","author":"Coomes","year":"2011","journal-title":"Cholesterol"},{"key":"key\n\t\t\t\t20171012072819_B8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171012072819_B9","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics","volume":"78","author":"Dieterle","year":"2006","journal-title":"Anal. Chem."},{"key":"key\n\t\t\t\t20171012072819_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60721-6","article-title":"Advances in chemotherapy of cancer in man","volume":"4","author":"Farber","year":"1956","journal-title":"Adv. Cancer Res."},{"key":"key\n\t\t\t\t20171012072819_B11","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1124\/dmd.109.027466","article-title":"Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease","volume":"37","author":"Fisher","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20171012072819_B12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cem.1359","article-title":"The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping","volume":"24","author":"Fonville","year":"2010","journal-title":"J. Chemometrics"},{"key":"key\n\t\t\t\t20171012072819_B13","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1046\/j.1523-1755.2001.59780221.x","article-title":"The folate cycle and disease in humans","volume":"78","author":"Fowler","year":"2001","journal-title":"Kidney Int. Suppl."},{"key":"key\n\t\t\t\t20171012072819_B14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0162-3109(00)00189-2","article-title":"Mechanisms of action of methotrexate","volume":"47","author":"Genestier","year":"2000","journal-title":"Immunopharmacology"},{"key":"key\n\t\t\t\t20171012072819_B15","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1124\/dmd.111.041012","article-title":"Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease","volume":"39","author":"Hardwick","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20171012072819_B16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mpo.2950170404","article-title":"Daily profiles of plasma phenylalanine and tyrosine in patients with osteogenic sarcoma during treatment with high-dose methotrexate-citrovorum rescue","volume":"17","author":"Hilton","year":"1989","journal-title":"Med. Pediatr. Oncol."},{"key":"key\n\t\t\t\t20171012072819_B17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/CS20110060","article-title":"Methionine and protein metabolism in non-alcoholic steatohepatitis: Evidence for lower rate of transmethylation of methionine","volume":"121","author":"Kalhan","year":"2011","journal-title":"Clin. Sci."},{"key":"key\n\t\t\t\t20171012072819_B18","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/dmd.111.040592","article-title":"Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease","volume":"39","author":"Lake","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20171012072819_B19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury","volume":"16","author":"Langman","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"key\n\t\t\t\t20171012072819_B20","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","article-title":"Animal models of NASH: Getting both pathology and metabolic context right","volume":"23","author":"Larter","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"key\n\t\t\t\t20171012072819_B21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012072819_B22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20171012072819_B23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/03602532.2011.577781","article-title":"Drug metabolism alterations in nonalcoholic fatty liver disease","volume":"43","author":"Merrell","year":"2011","journal-title":"Drug Metab. Rev."},{"key":"key\n\t\t\t\t20171012072819_B24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1440-1681.2000.03380.x","article-title":"Changes in absorptive function of rat intestine injured by methotrexate","volume":"27","author":"Naruhashi","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"key\n\t\t\t\t20171012072819_B25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ac00101a004","article-title":"750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma","volume":"67","author":"Nicholson","year":"1995","journal-title":"Anal. Chem."},{"key":"key\n\t\t\t\t20171012072819_B26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"key\n\t\t\t\t20171012072819_B27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u2018Metabonomics\u2019: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"key\n\t\t\t\t20171012072819_B28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"Perez-Carreras","year":"2003","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171012072819_B29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171012072819_B30","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171012072819_B31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0021-9258(19)68066-X","article-title":"The urinary excretion of formic acid and formiminoglutamic acid in folic acid deficiency","volume":"233","author":"Rabinowitz","year":"1958","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20171012072819_B32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"key\n\t\t\t\t20171012072819_B33","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1194\/jlr.M600198-JLR200","article-title":"Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1","volume":"47","author":"Rizki","year":"2006","journal-title":"J. Lipid Res."},{"key":"key\n\t\t\t\t20171012072819_B34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J. Hepatol."},{"key":"key\n\t\t\t\t20171012072819_B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03168215","article-title":"The influence of fasting on liver sulfhydryl groups, glutathione peroxidase and glutathione-S-transferase activities in the rat","volume":"60","author":"Szkudelski","year":"2004","journal-title":"J. Physiol. Biochem."},{"key":"key\n\t\t\t\t20171012072819_B36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171012072819_B37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3892\/etm.2012.567","article-title":"(1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis","volume":"4","author":"Wang","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"key\n\t\t\t\t20171012072819_B38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/tx049869b","article-title":"Metabonomic deconvolution of embedded toxicity: Application to thioacetamide hepato- and nephrotoxicity","volume":"18","author":"Waters","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"key\n\t\t\t\t20171012072819_B39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0889-857X(05)70365-3","article-title":"Methotrexate hepatotoxicity","volume":"23","author":"West","year":"1997","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"key\n\t\t\t\t20171012072819_B40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t20171012072819_B41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171012072819_B42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cbf.290060110","article-title":"Methotrexate: Studies on the cellular metabolism. I. Effect on mitochondrial oxygen uptake and oxidative phosphorylation","volume":"6","author":"Yamamoto","year":"1988","journal-title":"Cell Biochem. Funct."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/142\/1\/105\/16690219\/kfu160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T08:32:08Z","timestamp":1650011528000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/toxsci\/article\/142\/1\/105\/1707277\/Systems-Level-Metabolic-Phenotype-of-Methotrexate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,8,21]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfu160","relation":{},"ISSN":["1096-0929","1096-6080"],"issn-type":[{"value":"1096-0929","type":"electronic"},{"value":"1096-6080","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,8,21]]}}}